Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
30
MIRM Quote, Financials, Valuation and Earnings
Last price:
$39.55
Seasonality move
:
11.84%
Day range:
$38.14 - $39.89
52-week range:
$23.14 - $54.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.13x
P/B ratio:
8.60x
Volume:
512.1K
Avg. volume:
512.6K
1-year change:
53.23%
Market cap:
$1.9B
Revenue:
$336.9M
EPS (TTM):
-$1.85
Earnings Data
Next earnings date for MIRM
May 08
2025
Most recent earnings per share
-$0.49
Missed by $0.25
(Feb 26/2025)
Consensus Estimate
-$0.25
(Feb 26/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MIRM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $103.6M | -- | -- | -$0.23 | -- |
| 05/08/2025 | Q1 | $98.4M | -- | -- | -$0.27 | -- |
| 02/26/2025 | Q4 | $96.6M | $99.4M | -$0.49 | -$0.25 | -$0.25 |
| 11/12/2024 | Q3 | $82M | $90.4M | -$0.30 | -$0.45 | $0.15 |
| 08/07/2024 | Q2 | $75.1M | $77.9M | -$0.52 | -$0.46 | -$0.06 |
| 05/08/2024 | Q1 | $70.2M | $69.2M | -$0.54 | -$0.30 | -$0.24 |
| 02/28/2024 | Q4 | $67.9M | $69.6M | -$0.71 | -$0.22 | -$0.48 |
| 11/02/2023 | Q3 | -- | -- | -$0.57 | -$0.81 | $0.24 |
| 08/03/2023 | Q2 | -- | -- | -$1.94 | -$0.79 | -$1.15 |
| 05/04/2023 | Q1 | -- | -- | -$0.80 | -$0.97 | $0.17 |
| 03/08/2023 | Q4 | -- | -- | -$0.99 | -$0.92 | -$0.06 |
| 11/09/2022 | Q3 | -- | -- | -$1.02 | -$1.09 | $0.07 |
| 08/04/2022 | Q2 | -- | -- | -$0.84 | -$1.06 | $0.22 |
| 05/05/2022 | Q1 | -- | -- | -$1.17 | -$1.38 | $0.21 |
| 03/09/2022 | Q4 | -- | -- | $1.88 | $1.84 | $0.04 |
| 11/15/2021 | Q3 | -- | -- | -$1.55 | -$1.50 | -$0.05 |
| 08/05/2021 | Q2 | -- | -- | -$1.45 | -$1.08 | -$0.37 |
| 05/06/2021 | Q1 | -- | -- | -$1.68 | -$0.99 | -$0.70 |
| 03/09/2021 | Q4 | -- | -- | -$1.43 | -$0.98 | -$0.45 |
| 11/12/2020 | Q3 | -- | -- | -$0.86 | -$0.98 | $0.12 |
| 08/06/2020 | Q2 | -- | -- | -$0.93 | -$0.87 | -$0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.86 | -$0.84 | -$0.02 |
| 03/12/2020 | Q4 | -- | -- | -$0.79 | -$0.85 | $0.06 |
| 11/06/2019 | Q3 | -- | -- | -$0.84 | -$0.63 | -$0.21 |
| 08/28/2019 | Q2 | -- | -- | -$0.59 | -$0.59 | $0.00 |
Mirum Pharmaceuticals Earnings Questions
-
How Much did Mirum Pharmaceuticals Generate in Revenue Last Quarter?
Mirum Pharmaceuticals reported $99.4M worth of top line sales in its most recent quarter.
-
Did Mirum Pharmaceuticals Beat Earnings Last Quarter?
Mirum Pharmaceuticals announced earnings per share of -$0.49 which represents a miss of analyst forecast a -$0.25 per share.
-
Is Mirum Pharmaceuticals Profitable?
Mirum Pharmaceuticals reported $76.6M that represents $1.15 per share over the last quarter.
-
What is the Analyst Consensus for Mirum Pharmaceuticals EPS Next Year?
Mirum Pharmaceuticals's earnings are forecast to decrease from -$1.85 per share to -$0.81 per share next year representing a decrease of -54.46%.
-
When is Mirum Pharmaceuticals's Earnings Date?
Mirum Pharmaceuticals's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
